13 results
PRE 14A
TYRA
Tyra Biosciences Inc
5 Apr 24
Preliminary proxy
4:20pm
to areas of potential material risk, including operations, finance, legal, regulatory, strategic and reputational risk.
The Audit Committee reviews
DEF 14A
TYRA
Tyra Biosciences Inc
28 Apr 22
Definitive proxy
4:07pm
operations, finance, legal, regulatory, strategic and reputational risk.
The Audit Committee reviews information regarding liquidity and operations
10-K
18lcku
3 Mar 22
Annual report
4:31pm
10-Q
l8ow5 77bwtl
3 Nov 21
Quarterly report
4:31pm
424B4
3wj5b5r
15 Sep 21
Prospectus supplement with pricing info
4:10pm
S-1/A
xdnp1
9 Sep 21
IPO registration (amended)
6:08am
S-1
f3v7t lx8rq
20 Aug 21
IPO registration
4:07pm
DRS/A
bihta9vtw fxh01f
2 Jul 21
Draft registration statement (amended)
12:00am
DRS
f5uh3vdirkxxt572 6qd
28 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next